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The lysosomal endoprotease cathepsin D (CatD) is an essential player in general protein turnover and speciﬁc peptide
processing. CatD-deﬁciency is associated with neurodegenerative diseases, whereas elevated CatD levels correlate with tumor
malignancy and cancer cell survival. Here, we show that the CatD ortholog of the budding yeast Saccharomyces cerevisiae
(Pep4p) harbors a dual cytoprotective function, composed of an anti-apoptotic part, conferred by its proteolytic capacity, and an
anti-necrotic part, which resides in the protein’s proteolytically inactive propeptide. Thus, deletion of PEP4 resulted in both
apoptotic and necrotic cell death during chronological aging. Conversely, prolonged overexpression of Pep4p extended
chronological lifespan speciﬁcally through the protein’s anti-necrotic function. This function, which triggered histone
hypoacetylation, was dependent on polyamine biosynthesis and was exerted via enhanced intracellular levels of putrescine,
spermidine and its precursor S-adenosyl-methionine. Altogether, these data discriminate two pro-survival functions of yeast
CatD and provide ﬁrst insight into the physiological regulation of programmed necrosis in yeast.
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Cathepsin D (CatD) is an aspartic endoprotease that is
ubiquitouslypresentinlysosomesofallmammaliancelltypes.
Together with other members of the cathepsin family, it has a
central role in general protein turnover and participates in
tissue remodeling, as well as in the processing of antigens,
hormones and neuropeptides.
1 Mutations in CatD cause
human neuronal ceroid lipofuscinoses, a group of pediatric
neurodegenerative diseases collectively known as Batten
Disease.
1,2
CatD seems to have a pleiotropic role with respect to
programmed cell death (PCD). On the one hand, over-
expression and hypersecretion of its catalytically inactive
zymogene(pro-CatD)hasbeenconnectedtoincreasedtumor
cell survival.
3–6 On the other hand,CatD has also been shown
to promote cell death in response to various conditions.
4,7–9
WhethertheproteolyticactivityofCatDisrequiredforitslethal
function, however, remains a matter of debate.
4 Thus, the
differential contribution of pro-CatD and CatD to cell survival
and cell death is not yet clariﬁed and may depend on the
speciﬁc cellular context.
During the last years, it has become apparent that the
coremachineryexecutingPCDisphylogeneticallyconserved,
establishing the budding yeast Saccharomyces cerevisiae
as a valuable model organism to study apoptosis and
necrosis.
10–13 The yeast genome encodes orthologs of
central mammalian apoptotic proteins, including one caspase
(Yca1p), the serine protease OMI (Nma111p) or endo-
nuclease G (Nuc1p).
14–16 Yeast cell death has been linked
to complex apoptotic scenarios including mitochondrial outer
membrane permeabilization with cytochrome c release and
histone H2B phosphorylation that also participate in PCD of
mammalian cells.
17,18 Finally, chronological aging, which is
tightly associated with PCD, has been instrumental in
exploring phylogenetically conserved aging pathways that
are applicable to postmitotic mammalian cells.
19 During
chronological aging, yeast cells eventually die as they exhibit
biochemicalandmorphologicalmarkersofbothapoptosisand
necrosis.
20–22 Importantly, here necrosis largely occurs in a
coordinated manner and is not an uncontrolled process as
known from ‘classical necrosis’.
11 Thus, ‘programmed necro-
sis’ represents (besides apoptosis) a further PCD subroutine
present in yeast.
10,11
Driven by the aforementioned considerations, we decided
toinvestigatetheroleofPep4p(alsocalledyeastproteinaseA),
the yeast CatD ortholog,
23 on yeast aging and cell
death. Using chronological aging as a means to physio-
logically induce necrotic cell death, we show that prolonged
overexpression of Pep4p promotes survival by speciﬁcally
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www.nature.com/cddisreducing necrosis. We demonstrate that PEP4 deletion
exacerbates both apoptosis and necrosis during chrono-
logical aging. Suppression of apoptosis by Pep4p relies on its
proteolytic activity, whereas the repression of necrosis is
mediated by the proteolytically inactive Pep4p propeptide,
which promotes survival via a novel pathway, the stimulation
of spermidine biosynthesis.
Results
Deletion of PEP4 leads to combined apoptotic and
necrotic cell death during chronological aging. Pep4p
is an essential player in the S. cerevisiae vacuolar proteolytic
system, where it is important for both protein degradation and
maturation of several vacuolar hydrolases.
23,24 Consistently,
mutants deﬁcient in PEP4 (Dpep4) exhibit reduced protein
degradation and enhanced loss of viability under conditions
of nutritional stress.
24 Therefore, we ﬁrst assessed the
survival rate of Dpep4 during chronological aging, in which
nutrients are limited. Starting at day 3 of aging, Dpep4 cells
exhibited a dramatic decrease in clonogenic survival
compared with the wild type (Figure 1a). This accelerated
mortality was accompanied by an increased formation of
reactive oxygen species (ROS; Figures 1b and e), as
indicated by the enhanced superoxide-driven conversion of
non-ﬂuorescent dihydroethidium (DHE) into ﬂuorescent
ethidium (Eth). We next evaluated phosphatidylserine
externalization to the outer leaﬂet of the plasma
membrane, a typical phenotypic feature of apoptotic cells,
a
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Figure 1 Premature death of Dpep4 cells displays markers of apoptosis and necrosis. (a) Survival determined by clonogenicity of wild type and Dpep4 cells during
chronologicalaging.Dataindicatemeans±S.E.M(n¼4).(b)ROSproductionatdays1,3,5and7ofwildtypeandDpep4cellsduringchronologicalagingasdeterminedvia
DHE-Eth conversion. Data in B to D represent means±S.E.M. (n¼3; **Po0.01, ***Po0.001). In each experiment, 30000 cells were evaluated using ﬂow cytometry.
(c) Phosphatidylserine externalization and loss of membrane integrity of wild type and Dpep4 cells at days 1 and 5 of chronological aging as determined using Annexin V/PI
costaining. (d) DNA fragmentation of wild type and Dpep4 strains at days 1 and 5 of chronological aging as determined via TUNEL staining. (e) Fluorescence microscopic
sample pictures of DHE and Annexin V/PI staining of wild type and Dpep4 cells at days 1 and 5 of the experiments shown in B and C. DIC, differential interference contrast
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Cell Death and Diseasewhich can be monitored by binding of ﬂuorescein isothio-
cyanat (FITC)-conjugated Annexin V to the externalized
phosphatidylserine. In parallel, we assessed loss of
membrane integrity, a characteristic marker of necrosis, by
examining membrane permeability with propidium iodide
(PI). Annexin V/PI co-staining (Figures 1c and e) allowed
discrimination between early apoptosis (only Annexin V
stained cells), late apoptosis leading to secondary necrosis
(double stained cells) and primary necrosis (only
PI-stained cells).
11 The Dpep4 cells showed a combined
increase in apoptotic and necrotic populations (Figures 1c
and e). In addition, TdT-mediated dUTP-biotin nick end
labeling (TUNEL)-staining revealed enhanced apoptotic DNA
fragmentation, compared with the wild-type control
(Figure 1d). In conclusion, disruption of PEP4 exacerbates
both apoptosis and necrosis during chronological aging.
Overexpressed Pep4p exhibits a proteolytically
independent cytoprotective function during chronological
aging. Ectopic overexpression of wild-type Pep4p (WT-
Pep4p) throughout the aging experiments (Supplementary
Figure S1A) signiﬁcantly promoted survival, at least during
the early phase of chronological aging (Figures 2a and b). In
addition, overexpression of Pep4p signiﬁcantly protected
yeast cells from hydrogen peroxide-induced cell death
(Figure 2c), whereas PEP4 deletion resulted in the
opposite phenotype (Supplementary Figure S1B). This
aligns the cytoprotective effect of Pep4p with the commonly
observed increased resistance to oxidative stress in long-
lived mutants of several model organisms, including
Caenorhabditis elegans, Drosophila melanogaster, mice
and yeast.
25,26
Next, we generated a Pep4p-variant with two point
mutations in its catalytically active aspartic residues (D109A,
D294A) abrogating its proteolytic activity, as well as its ability
tostabilizeproteinaseB(Prb1p),akeyenzymeinthevacuolar
degradation system.
27 Surprisingly, the double-point mutant
(DPM-Pep4p) was undistinguishable from WT-Pep4p, with
regard to its pro-survival effect (Figures 2a and b). Of note,
overexpression of Pep4p conferred a comparable rescuing
effect in the deletion background of PRB1, further evidencing
that the observed pro-survival effect is independent from
Prb1p stabilization (Supplementary Figure S1C). In conclu-
sion, Pep4p improves the survival of aging yeast cells
independently of its proteolytic activity.
Pep4p is a crucial player in autophagy,
28 a pro-survival
degradative pathway central during nutrient starvation
and closely associated to longevity in different organisms
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Figure 2 OverexpressionofPep4poraproteolyticallyinactivemutantbothextendchronologicallifespan,whichcorrelateswith hypoacetylationofhistoneH3.(a)Survival
determined by clonogenicity of wild-type yeast cells overexpressing WT-Pep4p or DPM-Pep4p and survival of corresponding vector control during chronological aging. Data
represent means±S.E.M. (n¼4). (b) Immunoblots of whole cell extracts of wild-type cells overexpressing FLAG-tagged WT-Pep4p, FLAG-tagged DPM-Pep4p and the
corresponding vector control after 20h of induction. Blots were probed with antibodies against FLAG epitope or glyceraldehyde-3-phosphate-dehydrogenase as a loading
control. (c) Survival of wild-type cells overexpressing WT-Pep4p or harboring the vector control after 40h of induction and subsequent treatment, with or without hydrogen
peroxide (H2O2) for 4h. Survival of the corresponding controls was set to 100%. Data represent means±S.E.M. (n¼10 for controls, n¼7 for treated cultures;
***Po0.001).(d) Survivalof Datg8 cells overexpressing WT-Pep4por DPM-Pep4p andsurvival of vectorcontrol duringchronologicalaging. Data representmeans±S.E.M.
(n¼4). (e) Relative ALP activity indicative of autophagy during chronological aging of wild-type cells overexpressing WT-Pep4p, DPM-Pep4p or harboring the corresponding
vector control. Data represent means±S.E.M. (n¼4). (f) Relative acetylation of the H3 lysine residue K18 of wild-type cells overexpressing WT-Pep4p, DPM-Pep4p or
harboring the vector control at day 4 of chronological aging as determined by quantiﬁcation of immunoblot analyses. Data represent means±S.E.M. (n¼5 for WT-Pep4p,
n¼3 for DPM-Pep4p; *Po0.05, **Po0.01). See also Supplementary Figure S1
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29 However, overexpression of WT-Pep4p or
DPM-Pep4p in a mutant lacking ATG8, which is critical for
proper autophagosome formation, still retained its cytopro-
tective effects (Figure 2d). Autophagy deﬁciency accelerated
cell death during chronological aging, but, at least in the early
phase of chronological aging, did not prevent Pep4p-
mediated survival increase (Figure 2d) or reduction of ROS
accumulation (Supplementary Figure S1D). Autophagy-
independency was veriﬁed using an established biochemical
assay that follows the exclusively autophagy-driven vacuolar
delivery and subsequent activation of a truncated form of the
yeast alkaline phosphatase (ALP). As expected, overall
autophagy was enhanced with ongoing aging (Figure 2e).
However, overexpression of WT-Pep4p or DPM-Pep4p did
not result in an increased ALP-activity, compared with the
control, indicating no additional autophagy induction accom-
panying the pro-survival effect (Figure 2e). Thus, Pep4p
overexpression protectscellsfromaging-inducedcell deathin
an autophagy-independent manner.
Pep4p overexpression decreases histone H3 acetylation.
Histone deacetylation constitutes the epigenetic chromatin
modiﬁcation that is most consistently associated with life-
span extension and healthy aging in a wide range of
organisms.
20,30 Indeed, overexpression of WT-Pep4p and
DPM-Pep4p diminished acetylation of histone H3 (Figure 2f).
Reduced acetylation of histone residues has been
associated with lifespan extension of yeast in both
replicative
31 and chronological aging,
20 which model the
aging process in dividing cells and post-mitotic cells of higher
eukaryotes, respectively. However, the mechanisms
underlying hypoacetylation in each model seem to differ, as
SIR2, a histone deacetylase of the sirtuin family, promotes
lifespan during replicative aging, but has the opposite effects
on chronological lifespan.
32 Consistently, deletion of SIR2 did
not affect the pro-survival effect of Pep4p during chronologi-
cal aging (Supplementary Figure S1E). In conclusion,
Pep4p-mediated lifespan extension during chronological
aging seems to correlate with Sir2p-independent histone
deacetylation.
Pep4p promotes survival by inhibiting necrosis. Both
apoptosis and necrosis contribute to cell death with ongoing
aging.
20–22 The lifespan extension mediated by over-
expressed WT-Pep4p or DPM-Pep4p was accompanied by
diminished ROS production (Figure 3a) and a prominent
reduction in primary necrotic events, yet only slight reduction
in apoptosis (Figure 3b, Supplementary Figure S2A). We
further evaluated the ability of prolonged Pep4p
overexpression to reduce necrosis by monitoring nuclear
release of Nhp6Ap, the yeast homolog of the mammalian
high-mobility group box 1 protein (HMGB1). HMGB1 is a
chromatin-bound non-histone protein, whose nuclear release
may be associated with programmed necrosis, a controlled
rather than accidental type of necrotic cell death.
33
The nuclear fraction of Nhp6Ap, which was endogenously
tagged with green ﬂuorescent protein (GFP), diminished
with ongoing aging as determined by ﬂuorescence
microscopy (Figures 3c and d). Pep4p overexpression had
no effect on Nhp6Ap expression levels (Supplementary
Figure S2B), yet stimulated the nuclear retention of
Nhp6Ap (Figures 3c and d), thus conﬁrming its capacity to
inhibit necrosis.
The proteolytic activity of Pep4p is required for its anti-
apoptotic, but not for its anti-necrotic function. The
drastic survival deﬁciency displayed by the PEP4 deletion
mutant during chronological aging might involve a reduction
in vacuolar proteolysis with a consequent reduction in protein
recycling, degradation of oxidized proteins and/or activation
of other vacuolar hydrolases. Our results, however, suggest
the existence of an additional pro-survival role of Pep4p
during chronological aging that is independent of proteolysis.
To address this issue, we overexpressed either WT-Pep4p or
proteolysis-deﬁcient DPM-Pep4p in the PEP4 deletion
mutant. DPM-Pep4p (in contrast to WT-Pep4p) could not
fully complement PEP4 deﬁciency (Figure 3e). However,
DPM-Pep4p did confer a partial, yet signiﬁcant delay in the
onset of clonogenic death (Figure 3e) and retarded the
emergence of enhanced ROS production (Figure 3f), as
compared with the empty vector control. This indicates that
the requirement of the protein for healthy aging is
predominantly, but not solely, mediated by its proteolytic
function. Furthermore, DPM-Pep4p expressed in Dpep4 cells
speciﬁcally reduced the frequency of necrotic cell death
(Figure 3g), consistent with the data obtained in the wild-type
background (Figure 3b). In contrast, WT-Pep4p inhibited
both necrosis and apoptosis (Figure 3g, Supplementary
Figure S2C). Thus, the accelerated loss of viability exhibited
by Dpep4 during chronological aging is the result of the
combined loss of two separable Pep4p functions, a
proteolysis-dependent anti-apoptotic function and a non-
proteolytic anti-necrotic function.
The non-proteolytic anti-necrotic function of Pep4p
depends on polyamine biosynthesis. External admini-
stration of spermidine to yeast extends chronological
lifespan, correlating with global histone hypoacetylation and
reduced necrosis.
20 To investigate a possible connection
between Pep4p and polyamine biosynthesis, we over-
expressed Pep4p in cells that either are unable to generate
spermidine due to the lack of the S-adenosylmethionine
decarboxylase SPE2, or fail to convert spermidine to
spermine due to the absence of the spermine synthase
SPE4. The capacity of Pep4p to prolong lifespan, reduce
ROS production and inhibit necrosis was strongly diminished
in Dspe2, but not in Dspe4 cells (Figures 4a–c), although all
strains expressed comparable levels of Pep4p (Supple-
mentary Figure S3A). Therefore, polyamine synthesis up to
spermidine (but not spermine) generation is required for the
beneﬁcial effects of Pep4p on chronological aging.
Necrotic cell death during yeast chronological aging has
been previously associated with decline of internal polyamine
levels.
20 Indeed, the intracellular levels of spermidine and
putrescine, a precursor of spermidine, declined with age in
vector control cells (Figure 4d). This decline was signiﬁcantly
reduced in cells overexpressing WT-Pep4p (Figure 4d).
Conversely, decline of spermidine levels was accelerated
in the PEP4 deletion mutant, as compared with the wild
type (Supplementary Figure S3B). Moreover, intracellular
Pep4p inhibits yeast programmed necrosis
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Cell Death and Diseaseconcentrations of S-adenosyl-methionine (SAM), a precursor
to generate spermidine from putrescine, were increased upon
Pep4p overexpression (Figure 4d), conﬁrming the link
between Pep4p and polyamine synthesis.
Overexpression of Pep4p was generally accompanied by
an initial retardation of cell-cycle progression (data not
shown). However, this arrest disappeared at day 1–2 of
chronological aging, long before the pro-survival effects
emerged. In addition, overexpression of Pep4p in a deletion
strain that reduced its pro-survival effect (Dspe2) still
displayed an initial growth delay. These observations rule
out that the described effects are due to a cell cycle-mediated
retardation of aging.
The propeptide of Pep4p is sufﬁcient to mediate the
anti-necrotic effect. We next generated a series of mutants
with progressively shortened C-termini (not shown) and
observed that the anti-necrotic effect of Pep4p was
retained in all mutants, including the shortest one just
encoding the N-terminal 76-amino acid propeptide of the
Pep4p-zymogen, so far only known to harbor ER- and
vacuolar sorting signals (Figures 5a and b). Consistently,
prolonged overexpression of the Pep4p-propeptide (PRO-
Pep4p) during chronological aging reduced ROS production,
necrosis (Figures 5c and d) and nuclear Nhp6A-GFP release
(Supplementary Figure S4A), whereas it increased the
intracellular concentrations of SAM, putrescine and
spermidine (Supplementary Figure S4B). PRO-Pep4p
protected cells from hydrogen peroxide-induced cell death
(Figure 5e) and was capable of retarding the onset of death in
the Dpep4 mutant (Supplementary Figure S4C). Moreover, it
extended chronological lifespan in the Dspe4 mutant, yet lost
its beneﬁcial effects in the Dspe2 mutant (Supplementary
Figure S4D), although it was expressed at similar levels in
both deletion strains (Supplementary Figure S3A). In addition,
cytoprotection conferred by PRO-Pep4p was autophagy-
independent to the same extent as shown for WT-Pep4p
(Supplementary Figures S4E–G). Hence, the observed pro-
survival effect of WT-Pep4p and its proteolytically inactive
mutant (DPM-Pep4p) actually corresponds to a thus far
unknown spermidine-dependent anti-necrotic activity of the
Pep4p propeptide.
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Figure 3 Pep4p exerts its non-proteolytic pro-survival function via reduction of necrosis. (a and b) ROS production (a), phosphatidylserine externalization (b) and loss of
membrane integrity(b) at day 7 of chronological agingof wild-type cellsoverexpressing WT-Pep4p, DPM-Pep4por harboringthecontrol vectorasdeterminedvia DHE-Eth
conversion (a) and Annexin V/PI costaining (b). Data represent means±S.E.M. (n¼3; ***Po0.001). In each experiment, 30000 cells were evaluated using ﬂow cytometry.
(c and d) Nuclear localization of the yeast HMGB1 homolog (Nhp6Ap) via epiﬂuorescence microscopic analysis of endogenous chimeric fusion protein Nhp6Ap-GFP upon
WT-Pep4poverexpressionatdays1and7ofchronologicalaging.In(c)representativesamplepicturesaredepicted.(d)Showsmanualquantiﬁcationofatleast3000cellsper
strain and experiment, displaying nuclear localization of Nhp6Ap-GFP. Data represent means±S.E.M. (n¼3; **Po0.01). (e–g) Survival (e), ROS production (f),
phosphatidylserine externalization (g) and loss of membrane integrity (g)o fDpep4 cells overexpressing WT-Pep4p or DPM-Pep4p and of the correspondingvector control at
the indicated time points during chronological aging as determined via clonogenicity (e) DHE-Eth conversion (f) and Annexin V/PI costaining (g). Data represent
means±S.E.M. (n¼4; *Po0.05, **Po0.01, ***Po0.001). In (f) P-value was calculated for vector control and DPM-Pep4p. In each experiment for (f and g), 30000 cells
were evaluated using ﬂow cytometry. See also Supplementary Figure S2
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Combining clonogenic survival tests and the measurement of
characteristic cell death markers, we show that the proteo-
lytically inactive N-terminal propeptide of the yeast CatD
ortholog (Pep4p) suppresses necrosis in a genetically
regulated manner, arguing for the involvement of a cell death
type known as ‘programmed necrosis’.
10,11,33,34 In this case,
necrosis does not mainly result from strong cellular injury or
physical disruption of the plasma membrane as an accidental,
uncontrolled form ofcell death (‘classicalnecrosis’), but rather
follows an orchestrated program, similar to the regulated
apoptotic self-execution.
10,11
The anti-necrotic effect of Pep4p seems to involve the
regulation of polyamine synthesis (Figure 6), as it goes along
with an increase in the intracellular levels of putrescine,
spermidine and its biosynthetic precursor SAM. In addition,
Pep4p loses its anti-necrotic activity when spermidine
biosynthesis is blocked. Interestingly, external administration
of spermidine inhibits necrosis during yeast chronological
aging in a process involving histone hypoacetylation, a further
correlate of the Pep4p anti-necrotic activity.
20
The pro-survival effects of spermidine have been linked
to autophagy,
20 which is tightly connected to lifespan
extension
29 and Pep4p has a central role in the autophagic
process.
28 However, our data reveal that autophagy is not
required for the anti-necrotic effect of Pep4p, at least during
the early phase of chronological aging. Of note, it has been
recently reported that Pep4p overexpression confers autop-
hagy-independent cytoprotection upon acetic acid-induced
celldeath.
35Thoughtheanti-necroticfunctionofspermidineis
largely dependent on autophagy, during early aging, auto-
phagy-independent backup-mechanisms have been postu-
lated to exist.
20 Given the autophagy-independent yet
polyamine-associated nature of the anti-necrotic effect herein
described,itisprobablethatthesebackup-mechanismsmight
be related, at least in part, to Pep4p-driven inhibition of
programmed necrosis.
Intriguingly, both CatD hyperexpression, as well as in-
creased production of polyamines are observed in many
human cancers.
4,36 The propeptide of CatD has been
speciﬁcally associated to enhanced proliferation and survival
of tumor cells
3,5 and polyamines have been shown to mediate
tumorpromotionandprogression.
36Itistemptingtospeculate
that, like Pep4p, human CatD might represent a positive
regulator of polyamine biosynthesis and thus a unique target
for therapeutic intervention on cellular or tissue polyamine
pools. In addition, this study opens doors to investigate CatD
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Cell Death and Diseaseorthologues in pathological unicellular organisms as a target
for therapeutic necrosis induction.
Our results further provide evidence that Pep4p exerts dual
cytoprotective activities involving an anti-necrotic and an anti-
apoptotic function. Deletion of PEP4 causes premature death
during chronological aging resulting from a combination of
necrotic and apoptotic death. Overexpression of proteolyti-
cally inactive Pep4p in the PEP4 disruptant speciﬁcally
reduces the necrotic population and signiﬁcantly retards the
onset of cell death. However, substantial premature demise is
not prevented and the apoptotic population remains
unchanged. Thus, the requirement of Pep4p for healthy aging
is predominantly mediated by its proteolytic function
(Figure 6), which exhibits anti-apoptotic characteristics. However,
this anti-apoptotic activity isnot involved inlifespan extension;
wild type and enzymatically inactive Pep4p (or the sole
Pep4p propeptide) confer a similar degree of improved
survival through necrosis inhibition (but not apoptosis inhibi-
tion) when they are overexpressed in cells that contain
baseline levels of endogenous, catalytically active Pep4p. Of
note, CatD-deﬁcient neurons exhibit, besides autophagic
stress (aberrant accumulation of autophagosomes), also
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37,38 However, apoptosis does not seem
to be critical for neurodegeneration, suggesting alternative
deathmechanismsinvolvedinneuronaldeathfollowingCatD-
deﬁciency.
39 It would be interesting to analyze if a putative
increase in programmed necrosis is responsible for neuron
demise upon CatD deﬁciency.
Under the conditions tested here, Pep4p overexpression
protects cells from hydrogen peroxide-induced cell death,
which is in line with the enhanced resistance to oxidative
stress described for long-lived mutants. Nevertheless, it is
conceivable that, like its human counterpart, also yeast CatD
might bear a double function in regard to PCD. Thus, it
remains to be explored to which extent Pep4p may have a
regulatory role as an apoptotic and/or necrotic executioner
(in addition to its pro-survival roles) (Figure 6). In that case,
context-dependent regulatory processes could determine
whether the pro-survival or the lethal function of Pep4p
prevails.
In conclusion, this study uncovers a novel pro-survival
function of yeast CatD that is associated with polyamine
regulation and speciﬁcally exhibits anti-necrotic characteris-
tics, establishing that the capacity of yeast cells to undergo
programmed necrosis is under tight molecular control.
Materials and Methods
Yeast strains and plasmids. Experiments were carried out in BY4741
(MATa his3D1 leu2D0 met15D0 ura3D0) and respective null mutants, obtained
from Euroscarf. To monitor subcellular localization of endogenous Nhp6Ap, the
GFP-taggedNhp6Apyeaststrain(MATaleu2D0met15D0ura3D0)fromtheYeast-
GFP Clone Collection was used (Invitrogen, Lofer, Austria).
Allstrainsweregrown on SCmediumcontaining 0.17% yeastnitrogenbase (BD
Diagnostics, Schwechat, Austria), 0.5% (NH4)2SO4, 30mg/l of all amino acids
(except80mg/lhistidineand200mg/lleucine),30mg/ladenineand320mg/luracil,
with2%glucose(SCD).ForstrainscarryingaplasmidwithaPep4p-FLAGconstruct
eitherhistidine(pESC-His)oruracil(pESC-Ura)was notincludedand2%galactose
(SCG) was used for induction of expression.
To construct WT-Pep4p
FLAG, the insert was ampliﬁed by PCR using genomic
DNA as template, cut with EcoRI and NotI, and ligated into the vectors pESC-His or
pESC-Ura (Agilent Technologies, Stratagene, Santa Clara, CA, USA). To construct
DPM-Pep4p
FLAG, the Pep4p single point mutant D294A-Pep4p was ﬁrst generated
by a three-step PCR: two PCR products sharing homology in the point mutation
region were obtained using the correspondent WT-Pep4p primers and the
corresponding mutation-primers, respectively; WT-Pep4p-pESC vector served as
the template. These two PCR-products were combined and ampliﬁed using WT-
Pep4p-primers. The obtained PCR product was digested with EcoRI and NotI and
ligated into pESC-His or pESC-Ura (Stratagene). The same procedure was used to
generate the second point mutation D109A, however, utilizing D294A-Pep4p-pESC
as the template. To obtain the C-terminal Pep4p deletion mutants the different
constructs were ampliﬁed by PCR using genomic DNA as template with the
corresponding primers (see Supplementary Material for PRO-Pep4p
FLAG primer).
TheresultingconstructsweredigestedwithEcoRIandNotI, andligatedinto vectors
pESC-His or pESC-Ura (Stratagene). Correctness of all sequences was veriﬁed
(MWGBiotech,Ebersberg, Germany).All primers andrestrictionenzymesused are
listed in Supplementary Table S1.
Survivalplatingandtestsforcelldeathmarkers. Chronologicalaging
experiments overexpressing Pep4p or Pep4p-mutants were performed in SCG
without histidine, or without uracil, as described.
16,22 In experiments involving
Dspe2 (Figures 4a–c, Supplementary Figure S4D), unable to generate spermidine,
which is required for normal growth of yeast, all strains were supplemented with
spermidine (S4139, Sigma, Vienna, Austria) to assure sufﬁcient and reproducible
polyamine levels during growth phase, but at concentrations (500nM on plate to
streak the strains, 10nM in the overnightculture (ONC) and 10nM in the inoculated
culture) that allowed adequate diminution of supplemented polyamines upon entry
into stationary phase, where chronological aging begins. Notably, at least three
different clones were tested for any aging survival plating to rule out clonogenic
variation of the observed effects. Representative aging analyses are shown with at
least three independent cultures, aged at the same time. All aging analyses were
performed at least twice in total, with similar outcome.
Experiments involving treatment with hydrogen peroxide were performed as
previously described,
14 with the following modiﬁcation, in order not to challenge the
overexpressor strains during the above described initial retardation of cell-cycle
progression,hydrogenperoxidestresswasappliedafterthisarresthaddisappeared
(40h after induction) for 4h. As these cells were not in early exponential phase,
treatment with a higher hydrogen peroxide dose was necessary to achieve similar
death rates in the control strains to the ones previously described.
14 To assure
proper comparison to the overexpressor strains, the same modiﬁcations were
applied to the knockout analyses.
DHE staining (ROS production), Annexin V/PI costaining (apoptosis/necrosis marker)
andTUNELstaining(apoptosismarker)wereperformedandquantiﬁedbyﬂowcytometry
(BDFACSAria,BDBiosciences,Heidelberg,Germany)aspreviouslydescribed.
14Atotal
of 30000 cells per sample were evaluated using BD FACSDiva software (BD
Biosciences). The same samples were analyzed by ﬂuorescence microscopy.
As a further marker for necrosis, nuclear release of the yeast HMGB1 homolog
(Nhp6Ap) was monitored by epiﬂuorescence microscopy of endogenous chimeric
fusion protein Nhp6Ap-GFP upon WT-Pep4p overexpression. For that purpose,
yeast strains expressing chromosomally tagged Nhp6Ap-GFP (Invitrogen) and
transformed with pESC-Ura/PEP4 were aged in SCG lacking uracil. At indicated
time points, cells were washed once with PBS and directly applied to
epiﬂuorescence microscopy with the use of small-band GFP ﬁlter (Zeiss, Vienna,
Austria) in order to analyze nuclear localization of Nhp6A-GFP. Quantiﬁcation of
cells displaying nuclear localization of Nhp6A-GFP was performed manually,
counting at least 3000 cells per strain and experiment.
Pep4p
(yeast CatD)
anti-necrotic function
(propeptide, non-proteolytic)
vacuolar function
(proteolytic)
lethal function ?
(proteolytic ?)
S-adenosyl-methionine
putrescine, spermidine
histone acetylation
programmed necrosis
chronological lifespan
survival, longevity cell death
? general turnover  
zymogen activation
homeostasis
?
Figure 6 Yeast CatD’s functions in cell metabolism. Besides its central role in
the vacuolar proteolytic system, where it is a pivotal player for general protein
turnover and maturation of several vacuolar hydrolases, the yeast ortholog of CatD,
Pep4p, also holds a non-proteolytic function associated with its propeptide that
promotes survival via polyamine-mediated reduction of programmed necrosis. In
addition,yeastCatDmightbe involved intheinductionof PCDin speciﬁcscenarios,
as it has been described for its mammalian counterpart
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Cell Death and DiseaseMicroscopy. Microscopy was performed with a Zeiss Axioskop microscope
using a Zeiss Plan-Neoﬂuar objective lense with 40  magniﬁcation and 1.30
numerical aperture in oil (using Zeiss Immersol) at room temperature. Imaging
medium was AnnexinV/PI incubation buffer (10mM HEPES, 140mM NaCl, 5mM
CaCl2, pH 7.4) for pictures shown in Figure 1e and water for pictures shown in
Figure 3c. Fluorochromes were ﬂuorescein (used as FITC), PI and Eth (after
conversion from DHE) for pictures shown in Figure 1e and GFP for pictures shown
in Figure 3c. Fluorescence microscopic sample images were taken with a
DiagnosticInstrumentscamera(Model:SPOT9.0Monochrome-6,SterlingHeights,
MI, USA), acquired using the Metamorph software (version 6.2r4, Molecular
Devices, Sunnyvale, CA, USA) and processed with IrfanView (version 3.97, Wiener
Neustadt, Austria) and Adobe Photoshop (version CS2) software. Speciﬁcally,
picture processing involved creation of AnnexinV and PI overlays in Figure 1e, and
coloring (Figures 1e and 3c) with Metamorph and cropping of representative areas
(Figure 3c) with Irfanview. In addition, for pictures in Figure 1e, contrast and
brightness was adjusted with Adobe Photoshop (applying equal adjustment
parameters to all pictures); for GFP-pictures in Figure 3c, equal contrast-, saturation-
and gamma correction was applied for pictures of the same day with Irfanview
(gamma correction: 0.35 for day1-pictures and 1.3 for day7-pictures).
Alkaline phosphatase (ALP) assay. Autophagy was monitored by ALP
activity.
40StrainscarryingaplasmidwitheitherWT-Pep4p,DPM-Pep4p,PRO-Pep4por
thevectorcontrolweretransformedwithandselectedforstableinsertionofpTN9HindIII
fragment (conﬁrmed by PCR). In order to correct for intrinsic (background) ALP activity,
the corresponding strains without pTN9 were simultaneously processed and ALP
activity substracted. Relative ﬂuorescence units were determined by using a
ﬂuorescence reader (Tecan, GeniusPRO, Gro ¨dig, Austria) and applying a manual
gain of 25. Retention of the pro-survival effect during chronological aging in the pTN9
transformants was conﬁrmed by clonogenic plating assays (data not shown). For each
transformed strain, two clones were tested.
Immunoblotting. Preparation of cell extracts and immunoblotting were
performed as described.
16 Blots were probed with murine monoclonal antibodies
against FLAG-epitope (Sigma), murine monoclonal antibodies against
glyceraldehyde-3-phosphate dehydrogenase (Sigma) and the respective
peroxidase-conjugated afﬁnity-puriﬁed secondary antibody (Sigma).
Quantiﬁcation of histone acetylation. Trichloroacetic acid whole-cell
extracts from at least three independent experiments for each strain were prepared
aspreviouslydescribed.
20 Proteinswereseparatedon15%SDS-PAGEforwestern
blot analysis on PVDF membrane (Millipore, Vienna, Austria) as described,
16 using
CAPS buffer (10% methanol, 10% 3-(Cyclohexylamino)-1-propanesulfonic acid
from Sigma) for transfer of proteins. Blots were probed with a rabbit polyclonal
antibody against histone H3 (ab1791, Abcam, Cambridge, UK; 1:5000), which
served as a loading control for total histone H3, as well as with a histone H3
modiﬁcation antibody K18ac (Upstate Biotechnology, Millipore, Vienna, Austria;
1:10000). Peroxidase-conjugated afﬁnity-puriﬁed secondary antibody was
obtained from Sigma.
For quantiﬁcation of relative acetylation, blots were scanned using a
densitometer (Molecular Dynamics, Model P.D. 300, Sunnyvale, CA, USA) and
quantiﬁed with ImageQuant Version 5.1 (Molecular Dynamics). Only band densities
with relative pixel intensities 4500 and o7000 were considered qualitatively valid
forquantiﬁcation.Band densitiesof acetylationspeciﬁcblotswerenormalizedtothe
respective densities of total histone H3 blots in order to obtain speciﬁc acetylation
rates for each sample. Acetylation rates of wild-type control cultures were set to 1
and the relative acetylation of each sample was calculated accordingly.
Extraction and measurements of polyamines and SAM. Extraction
and measurements of polyamines were essentially performed as described in
Eisenberg et al.
20 For acid extraction of polyamines from yeast cells, culture
equivalents of 20 OD600 were washed three times with ddH2O, resuspended in
400ml ice-cold 5% TCA and incubated on ice for 1h, with vortexing every 15min.
Supernatants were neutralized with 100mlo f2MK 2HPO4 and stored at  801C
upon polyamine measurements. Polyamines were determined using LC/MS/MS.
For determination of SAM levels, acid extraction was performed as described
for polyamines, and SAM-concentrations were detected using LC/MS/MS. All
experiments were carried out on an Ultimate 3000 System (Dionex, LCPackings,
Vienna, Austria) coupled to a Quantum TSQ Ultra AM (ThermoFinnigan, Vienna,
Austria),usinganAPCIionsource.ThesystemwascontrolledbyXcaliburSoftware
1.4. The stationary phase was a Sequant ZIC-HILIC column (150 2.1mm, 3mm,
100A ˚). The elution solvent A was 50mM ammonium formiate in ultra pure water
and solvent B was acetonitrile. Separation was performed with 15% acetonitrile for
2min. Thereafter, the acetonitrile content was linearly decreased to 5% over 2min.
After 1min, acetonitrile content was increased to 15% for column equilibration. Flow
rate was set to 300ml/min.
Polyamines and SAM were detected in MRM mode using the following
transitions: spermidine (m/z 146 Z72, CE 34eV), putrescine (m/z 89 Z72, CE
28eV), SAM (298 Z136, CE 13eV), bis(hexamethylene)-triamine as internal
standard (m/z 216 Z100, CE 36eV). Calibration standards were prepared by
spiking extraction buffer with specic concentrations of spermidine, putrescine, SAM
and internal standard. Volumes of 20ml of each sample were injected.
Statistical analyses. Error bars (±S.E.M.) are shown for independent
experiments. In cases when experiments were performed in parallel, a common
ONC for each strain was used and (i) fresh medium in separate ﬂasks was
inoculated directly from the corresponding ONCs (knockout studies) or (ii) common
pre-cultures in glucose medium for each strain were inoculated from the
corresponding ONCs and divided into separate ﬂasks after shifting to galactose
medium for expression induction (overexpression studies). The number of
independent data points (n) is indicated in the ﬁgure legends of the
corresponding graphs. Signiﬁcances were calculated using an ANOVA and were
corrected by the Bonferroni post hoc test. For aging experiments, a two-factor
ANOVA with strain and time as independent factors was applied.
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